What about the subscription to the journal that dcvax-l will be in. NEJM 89/year, print and online, don't forget that flipper. Does the 89 bucks cover anything else? Mug? Inserts?
No subscription, no journal, no journal no dcvax, no dcvax, no glioblastoma survivors.
I’m inclined to agree with your thoughts on this. Chicken and egg scenario - they and only they can gauge the likely uptick in patient numbers going through at scale at Sawston post GMP certification but more importantly post TLD announcement….that is likely to create a surge in demand even at $200k a pop. Recruiting qualified staff takes 2-3 months and then every employee needs a couple of months to genuinely start delivering a tangible net difference. Seems a smart move. I’m less inclined to believe a BLA application but that’s just my opinion.